- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Godavari Biorefineries Limited — Updates, 17-12-2025: Press Release
17-12-2025 | 04:58 pm
17-12-2025 | 04:58 pm
Godavari Biorefineries' Sathgen Therapeutics launched a US subsidiary, expanding its clinical-stage biotech presence. This aims to accelerate novel cancer drug development and global intellectual property out-licensing, strengthening key partnerships.
No comments yet. Be the first to comment!